Pharmicell Co., Ltd. (KRX: 005690)

Pharmicell Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun 30, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Cash & Equivalents	6,727	1,631	11,013	3,591	8,194	7,944
Short-Term Investments	2,715	880.22	10,076	5,497	560.88	-
Cash & Short-Term Investments	9,443	2,512	21,089	9,088	8,754	7,944
Cash Growth	-41.49%	-88.09%	132.07%	3.81%	10.20%	557.54%
Accounts Receivable	3,503	5,439	5,710	1,987	3,913	4,631
Other Receivables	1,705	759.21	977.82	1,024	803.94	104.85
Receivables	5,208	6,198	6,688	3,011	4,717	5,735
Inventory	3,200	4,614	5,026	2,424	2,155	415.32
Prepaid Expenses	93.68	85.75	121.96	174.41	442.04	11.21
Other Current Assets	797.07	510.76	575.19	331.93	222.48	274.38
Total Current Assets	18,742	13,919	33,500	15,029	16,291	14,380
Property, Plant & Equipment	4,568	5,729	6,030	3,666	1,235	690.06
Long-Term Investments	2.5	2.5	1,382	930	380	20
Goodwill	34,551	34,551	36,107	26,514	-	-
Other Intangible Assets	207.11	223.8	215	219.72	65.47	113.16
Long-Term Accounts Receivable	-	-	-	8	22	-
Long-Term Deferred Tax Assets	-	-	-	969.8	-	-
Long-Term Deferred Charges	41,900	41,797	55,708	51,216	5,500	2,500
Other Long-Term Assets	2,203	3,146	3,485	2,600	6,252	4,969
Total Assets	102,174	99,369	136,427	101,153	29,745	23,472
Accounts Payable	775.18	1,951	2,469	549.64	1,086	214.56
Accrued Expenses	338.17	671.28	777.5	3	222.5	143.81
Short-Term Debt	11,744	8,841	27,118	14,800	13,894	1,700
Current Portion of Long-Term Debt	-	-	49.98	166.64	-	-
Current Unearned Revenue	82.56	71.34	44.67	-	-	0.9
Other Current Liabilities	1,079	1,297	717.09	959.93	3,967	598.27
Total Current Liabilities	14,018	12,831	31,176	16,479	19,170	2,658
Long-Term Debt	-	-	-	249.96	-	7,010
Long-Term Unearned Revenue	940.77	822.13	506.5	1.62	2.94	12.45
Other Long-Term Liabilities	128.7	180.79	203.53	416.68	450.88	-
Total Liabilities	17,903	16,948	34,845	18,333	19,840	9,680
Common Stock	22,564	21,703	20,934	16,631	11,376	9,538
Additional Paid-In Capital	145,561	139,412	133,694	100,686	16,478	10,345
Retained Earnings	-85,582	-80,136	-54,579	-36,955	-18,423	-6,221
Treasury Stock	-114.83	-114.83	-114.83	-114.83	-15	-
Comprensive Income & Other	1,843	1,592	1,681	2,601	502.46	129.89
Total Common Equity	84,271	82,455	101,616	82,848	9,919	13,792
Minority Interest	0.08	-34.53	-34.15	-27.45	-14.18	-
Shareholders' Equity	84,271	82,421	101,582	82,820	9,905	13,792
Total Liabilities & Equity	102,174	99,369	136,427	101,153	29,745	23,472
Total Debt	11,744	8,841	27,168	15,217	13,894	8,710
Net Cash (Debt)	-2,301	-6,330	-6,078	-6,129	-5,140	-766.38
Net Cash Per Share	-52.72	-149.71	-160.89	-234.39	-2480.35	-49.92
Filing Date Shares Outstanding	45.12	43.39	41.86	33.25	22.75	19.08
Total Common Shares Outstanding	45.12	43.39	41.86	33.25	22.75	19.08
Working Capital	4,724	1,088	2,324	-1,450	-2,879	11,723
Book Value Per Share	1867.90	1900.23	2427.77	2491.75	435.96	723.03
Tangible Book Value	49,513	47,681	65,294	56,114	9,854	13,679
Tangible Book Value Per Share	1097.47	1098.82	1559.97	1687.70	433.08	717.10
Land	1,041	1,766	1,766	1,255	-	-
Buildings	2,230	2,373	2,373	660	-	-
Machinery	5,938	5,892	5,417	3,477	2,390	1,852
Construction In Progress	-	-	-	7	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.